Polycurious? Or perhaps you’re simply curious to know more about the word polyamory? We’ve got you covered with a special ...

Approval of Adcetris provides a new treatment option for patients with relapsed or refractory large b-cell lymphoma who are ...

The FDA accepted Regeneron’s BLA resubmission for linvoseltamab in relapsed or refractory multiple myeloma, with a decision ...

OnCusp Therapeutics receives US FDA fast track designation for CUSP06 for treatment of platinum-resistant ovarian cancer: Princeton, New Jersey Saturday, February 15, 2025, 15:00 ...

President Trump's crackdown on undocumented immigrants has disrupted life for thousands of families and may leave many people ...

February 14, 2025) - The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Applied Therapeutics, Inc. (NASDAQ: APLT) securities between January 3, 2024 and ...

The Defense Department has told the military services to reach out once again to service members who were forced out or ...

Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union (EU) and the United Kingdom (UK) for the first authorized use of an ...

Frustrations over the permit approval for a pipeline in North Dakota has led some lawmakers to propose change to the makeup ...

Every baby food product packaged in jars, pouches, tubs and boxes sold in California must carry a QR code on its label that consumers can scan to check the most recent heavy metal readings, although ...

TORONTO, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory ...

The City of OKC is inviting students to its hiring event for full- and part-time positions with the City of Oklahoma City. Sophomores are also encouraged to attend that are interested in learning ...